tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ANNX Stock Latest News

Annexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
RatingsAnnexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
5d ago
ANNX
Annexon announces tanruprubart trial meets primary endpoint
PremiumThe Fly
Annexon announces tanruprubart trial meets primary endpoint
7d ago
ANNX
Needham healthcare analysts hold analyst/industry conference call
PremiumThe Fly
Needham healthcare analysts hold analyst/industry conference call
13d ago
JNJ
NVS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
26d ago
PLX
SLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
27d ago
PLX
ANNX
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & IdeasWells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
1M ago
ANAB
ANNX
Annexon price target lowered to $11 from $12 at BofA
Premium
The Fly
Annexon price target lowered to $11 from $12 at BofA
1M ago
ANNX
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating
Premium
Ratings
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating
1M ago
ANNX
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating
PremiumRatings
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating
1M ago
ANNX
Promising Potential of Annexon Biosciences’ ANX1502 Drives Buy Rating Amid Positive Clinical Data
PremiumRatings
Promising Potential of Annexon Biosciences’ ANX1502 Drives Buy Rating Amid Positive Clinical Data
1M ago
ANNX
Annexon price target lowered to $20 from $30 at H.C. Wainwright
PremiumThe Fly
Annexon price target lowered to $20 from $30 at H.C. Wainwright
1M ago
ANNX
Strategic Advancements and Financial Stability Drive Buy Rating for Annexon Biosciences
PremiumRatings
Strategic Advancements and Financial Stability Drive Buy Rating for Annexon Biosciences
1M ago
ANNX
Annexon Biosciences Reports Strong Progress in 2024
PremiumCompany AnnouncementsAnnexon Biosciences Reports Strong Progress in 2024
1M ago
ANNX
Annexon reports Q4 EPS (33c), consensus (29c)
Premium
The Fly
Annexon reports Q4 EPS (33c), consensus (29c)
1M ago
ANNX
Annexon reports inducement grants under Nasdaq listing rule
Premium
The Fly
Annexon reports inducement grants under Nasdaq listing rule
2M ago
ANNX
Annexon announces 2025 strategic priorities, key catalysts
PremiumThe Fly
Annexon announces 2025 strategic priorities, key catalysts
3M ago
ANNX
Annexon Biosciences Strengthens Board for Strategic Growth
PremiumCompany Announcements
Annexon Biosciences Strengthens Board for Strategic Growth
3M ago
8K
ANNX
Annexon appoints William Jones to board of directors
PremiumThe Fly
Annexon appoints William Jones to board of directors
3M ago
ANNX
NAMS
Annexon (ANNX) Surges with Promising Phase 3 Results for Guillain-Barré Syndrome Treatment
PremiumMarket News
Annexon (ANNX) Surges with Promising Phase 3 Results for Guillain-Barré Syndrome Treatment
4M ago
ANNX
Annexon announces topline results from RWE study of ANX005 in GBS
PremiumThe FlyAnnexon announces topline results from RWE study of ANX005 in GBS
4M ago
ANNX
Annexon to present Phase 2 ARCHER DATA on ANX007
Premium
The Fly
Annexon to present Phase 2 ARCHER DATA on ANX007
4M ago
ANNX
Annexon Biosciences Reports Q3 Financial Results
Premium
Company Announcements
Annexon Biosciences Reports Q3 Financial Results
5M ago
ANNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >